BI talks strategy, creative behind Ofev DTC ad by Beth Snyder Bulik Monday, April 15, 2019 Boehringer Ingelheim talks about its winning strategy for IPF treatment Ofev as the winner of #FierceMadness DTC 2019.
Boehringer Ingelheim’s Ofev takes #FierceMadness championship by Beth Snyder Bulik, Carly Helfand Monday, April 8, 2019 Boehringer Ingelheim’s ad campaign for Ofev pulled away from GlaxoSmithKline’s Trelegy to land the #FierceMadness ad tournament crown.
#FierceMadness final: It's GSK's Trelegy vs. Boehringer's Ofev by Beth Snyder Bulik, Carly Helfand Wednesday, April 3, 2019 The #FierceMadness final game is set—and it’ll be GlaxoSmithKline's Trelegy taking on Boehringer Ingelheim's Ofev for the 2019 title.
Amgen, GSK, Novartis, BI spots are the #FierceMadness Final Four by Beth Snyder Bulik, Carly Helfand Monday, April 1, 2019 #FierceMadness DTC is down to Repatha versus Trelegy, while Aimovig will take on Ofev in a short round of voting that ends Tuesday at midnight.
Ads get ready to rumble in the #FierceMadness Sweet 16 by Beth Snyder Bulik, Carly Helfand Monday, March 25, 2019 FierceMadness Round 2 results are in, with 16 contenders remaining in the March Madness-style pharma DTC ad tournament.
#FierceMadness voters bounce Liotta, Tremfya in Round 1 by Beth Snyder Bulik, Carly Helfand Wednesday, March 20, 2019 First-round winners in the #FierceMadness ad tournament are decided, with the victors advancing to compete in Round 2's field of 32.
#FierceMadness is back with 2019's pharma ad tournament by Beth Snyder Bulik Monday, March 18, 2019 If it’s March, it must be #FierceMadness, our annual take on the March Madness NCAA basketball tournament and bracket mania—with a pharma twist.
